Rein Therapeutics, Inc. Common Stock (RNTX) is a publicly traded Healthcare sector company. As of July 21, 2026, RNTX trades at $0.86 with a market cap of $73.74M and a P/E ratio of -0.44. RNTX moved +1.23% today. Year to date, RNTX is -21.12%; over the trailing twelve months it is -40.56%. Its 52-week range spans $0.83 to $3.50. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces RNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for RNTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $73.74M |
| P/E Ratio | -0.44 |
| EPS | $-1.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.50 |
| 52-Week Low | $0.83 |
| Volume | 230.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-49.87M |
| Gross Margin | 0.00% |
1 analysts cover RNTX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.